Report Summarizes Cancer Study Findings from U.S. Food and Drug Administration (FDA) (Us Food and Drug Administration Approval Summary: Elacestrant for Estrogen Receptor-positive, Human Epidermal Growth Factor Receptor 2-negative, ...)

Media coverage

• Title	Report Summarizes Cancer Study Findings from U.S. Food and Drug Administration (FDA) (Us Food and Drug Administration Approval Summary: Elacestrant for Estrogen Receptor-positive, Human Epidermal Growth Factor Receptor 2-negative, ...)
  Media name/outlet	CDC & FDA Daily
  Country/Territory	United States
  Date	06/25/24
  Persons	Xin Gao